In conclusion, we hypothesize that sildenafil can be potentially used to improve insulin action in type 2 diabetic patients leading to new therapeutic strategies for type 2 diabetes and other related cardiovascular disease. This evidence concerns the gene INS and type 2 diabetes mellitus.